Skip to main content

Diabetic Neuropathy News

Neuropathy Nerve Damage Often Goes Undiagnosed

THURSDAY, May 9, 2024 — Though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of falls, infection and even amputation. Neuropathy is n...

Nerve Decompression May Ease Painful Diabetic Peripheral Neuropathy

THURSDAY, March 28, 2024 – For patients with lower-extremity painful diabetic peripheral neuropathy (DPN), nerve decompression is associated with reduced pain, although these effects may be partly...

Diabetes Complications More Common in Patients Not Living in Urban Areas

WEDNESDAY, March 27, 2024 – Adults with diabetes living in small towns are disproportionately impacted by complications of diabetes, according to a study published online Feb. 22 in Diabetes Care. ...

Nerve Treatment Could Help Ease Diabetic Neuropathy

FRIDAY, March 22, 2024 – A surgical treatment used to treat conditions like carpal tunnel syndrome and back sciatica might also help relieve the pain of patients with diabetic neuropathy, a new...

Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet

AACHEN, Germany and MORRISTOWN, N.J., July 21, 2020 /PRNewswire/ – Grünenthal announced today that its U.S. subsidiary Averitas Pharma, Inc. received U.S. Food and Drug Administration (FDA) approval ...

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions

October 12, 2017 - Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved Lyrica CR (pregabalin) extended-release tablets CV as once-daily...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

gabapentin, Cymbalta, Lyrica, duloxetine, pregabalin, topiramate, nortriptyline